Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Inhibition of angiogenesis by the antifungal drug itraconazole.

Chong CR, Xu J, Lu J, Bhat S, Sullivan DJ Jr, Liu JO.

ACS Chem Biol. 2007 Apr 24;2(4):263-70.

PMID:
17432820
2.

Itraconazole inhibits HMEC-1 angiogenesis.

Del Carratore R, Carpi A, Beffy P, Lubrano V, Giorgetti L, Maserti BE, Carluccio MA, Simili M, Iervasi G, Balzan S.

Biomed Pharmacother. 2012 Jun;66(4):312-7. doi: 10.1016/j.biopha.2011.11.004. Epub 2011 Dec 21.

PMID:
22564244
3.

CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.

Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.

Cancer Res. 2003 Sep 15;63(18):5978-91. Erratum in: Cancer Res. 2003 Nov 1;63(21):7543.

5.

Anti-angiogenic function of tocotrienol.

Miyazawa T, Shibata A, Nakagawa K, Tsuzuki T.

Asia Pac J Clin Nutr. 2008;17 Suppl 1:253-6.

6.
7.

Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.

Shinkaruk S, Bayle M, Laïn G, Déléris G.

Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. Review.

PMID:
12678905
8.

Antitumor activities of synthetic and natural stilbenes through antiangiogenic action.

Kimura Y, Sumiyoshi M, Baba K.

Cancer Sci. 2008 Oct;99(10):2083-96. doi: 10.1111/j.1349-7006.2008.00948.x.

9.

Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.

Sun J, Blaskovich MA, Jain RK, Delarue F, Paris D, Brem S, Wotoczek-Obadia M, Lin Q, Coppola D, Choi K, Mullan M, Hamilton AD, Sebti SM.

Cancer Res. 2004 May 15;64(10):3586-92.

10.

Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.

Hagedorn M, Zilberberg L, Wilting J, Canron X, Carrabba G, Giussani C, Pluderi M, Bello L, Bikfalvi A.

Cancer Res. 2002 Dec 1;62(23):6884-90.

11.

VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo.

Ueda Y, Yamagishi T, Ikeya H, Hirayama N, Itokawa T, Aozuka Y, Samata K, Nakaike S, Tanaka M, Ono M, Saiki I.

Anticancer Res. 2004 Sep-Oct;24(5A):3009-17.

12.

PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.

Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, Hofmann F, Mestan J, Mett H, O'Reilly T, Persohn E, Rösel J, Schnell C, Stover D, Theuer A, Towbin H, Wenger F, Woods-Cook K, Menrad A, Siemeister G, Schirner M, Thierauch KH, Schneider MR, Drevs J, Martiny-Baron G, Totzke F.

Cancer Res. 2000 Apr 15;60(8):2178-89.

13.

Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.

Reinmuth N, Liu W, Ahmad SA, Fan F, Stoeltzing O, Parikh AA, Bucana CD, Gallick GE, Nickols MA, Westlin WF, Ellis LM.

Cancer Res. 2003 May 1;63(9):2079-87.

14.

Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor.

Kong D, Okamura M, Yoshimi H, Yamori T.

Eur J Cancer. 2009 Mar;45(5):857-65. doi: 10.1016/j.ejca.2008.12.007. Epub 2009 Jan 12.

PMID:
19144509
15.

Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.

Drevs J, Fakler J, Eisele S, Medinger M, Bing G, Esser N, Marmé D, Unger C.

Anticancer Res. 2004 May-Jun;24(3a):1759-63.

16.

3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.

Park HJ, Kong D, Iruela-Arispe L, Begley U, Tang D, Galper JB.

Circ Res. 2002 Jul 26;91(2):143-50.

17.

A quantitative ELISA-based co-culture angiogenesis and cell proliferation assay.

Friis T, Kjaer Sørensen B, Engel AM, Rygaard J, Houen G.

APMIS. 2003 Jun;111(6):658-68.

PMID:
12969022
18.
19.

1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo.

Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE.

Circ Res. 2000 Aug 4;87(3):214-20.

20.

Development of new drugs in angiogenesis.

Ziche M, Donnini S, Morbidelli L.

Curr Drug Targets. 2004 Jul;5(5):485-93. Review.

PMID:
15216914

Supplemental Content

Support Center